Telomir Pharmaceuticals

TELONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$79.779 M

$1.16 -0.85%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$10.4M

Loss-making

Shares outstanding

34,380,971

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#318LifevantageLFVN$85.3M
#319Alterity TherapeuticsATHE$80.7M
#320Telomir PharmaceuticalsTELO$79.8M
#321Gain TherapeuticsGANX$77.6M
#322Adicet BioACET$74.7M

Where these numbers come from

Share counts and financials for Telomir Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.